AIM To examine sleep quality and its determinants among people with type 2 diabetes mellitus(T2DM).METHODS This is a cross-sectional study conducted among diabetic patients referring to Ardabil diabetes clinic in Nort...AIM To examine sleep quality and its determinants among people with type 2 diabetes mellitus(T2DM).METHODS This is a cross-sectional study conducted among diabetic patients referring to Ardabil diabetes clinic in Northwest of Iran. Information on sleep quality was collected using Pittsburg Sleep Quality Index(PSQI). A questionnaire was used to collect data on sociodemographic lifestyle factors and psychological distress. This questionnaire was completed through an interview, and clinical information was extracted from patient's record. Data analysis was done using SPSS software version 23 and univariate andmultivariate analyses.RESULTS Study participants consist of 256 people with T2 DM the majority of whom were women(70%), and mean age of participants was 54.06 ± 9.09. The mean of total score of PSQI was 5.56 ± 3.34. Relative to younger age group, the middle-aged people with T2 DM were twice more likely to be poor sleeper; the adjusted OR was 2.03(95%CI: 1.01-4.08); and those with longer duration of diabetes were about 1.8 times more likely to report poor quality of sleep(ORadj = 1.77, 95%CI: 0.98-3.13). Participants with cholesterol level ≥ 240 mg/dL were about twice more likely to be poor sleeper(ORadj = 1.99, 95%CI: 1.01-3.94). The odds of being poor sleeper increased as the level of distress increased(1.84-4.09).CONCLUSION As indicated by the results of the present study, some factors including age, duration of disease, psychological distress and high level of cholesterol were independently associated with poor sleep quality.展开更多
目的探讨复方苦参注射液用于WHO三阶梯止痛原则中的止痛价值。方法随机选取医院2019年7月—2022年4月150例癌痛患者,按照随机数字表法分为治疗组75例,对照组75例。对照组轻度癌痛患者使用布洛芬缓释片,中度癌痛患者使用盐酸曲马多缓释...目的探讨复方苦参注射液用于WHO三阶梯止痛原则中的止痛价值。方法随机选取医院2019年7月—2022年4月150例癌痛患者,按照随机数字表法分为治疗组75例,对照组75例。对照组轻度癌痛患者使用布洛芬缓释片,中度癌痛患者使用盐酸曲马多缓释片联合布洛芬缓释片,重度癌痛患者使用盐酸吗啡缓释片联合布洛芬缓释片联合醋酸地塞米松片处理,治疗组在对照组基础上加用复方苦参注射液,21 d为1个疗程。观察比较两组治疗后的疼痛有效缓解率以及疼痛程度数字评估量表(numerical rating scale,NRS)、EORTC QLQ—C30(EuroPean organization for Research and Treatment)量表评分、匹兹堡睡眠质量指数与安全性。结果经治疗,治疗组有效缓解率升高(P<0.05);治疗组的NRS评分明显升高(P<0.01);EORTC QLQ—C30量表评分部分升高(P<0.05);匹兹堡睡眠质量指数明显升高(P<0.01);两组在治疗期间均出现不良反应,但治疗组不良事件发生率在恶心呕吐与便秘两方面更低(P<0.05);结果差异均有统计学意义(P<0.05)。结论在WHO三阶梯止痛原则基础上,加用复方苦参注射液可以明显提高止痛效果,明显改善生活质量,提高患者睡眠质量,同时也可降低不良事件发生情况,因此值得在临床推广应用。展开更多
基金Supported by Research Council,Faculty of Health Sciences,Tabriz University of Medical Sciences grant,No.5.53.4452
文摘AIM To examine sleep quality and its determinants among people with type 2 diabetes mellitus(T2DM).METHODS This is a cross-sectional study conducted among diabetic patients referring to Ardabil diabetes clinic in Northwest of Iran. Information on sleep quality was collected using Pittsburg Sleep Quality Index(PSQI). A questionnaire was used to collect data on sociodemographic lifestyle factors and psychological distress. This questionnaire was completed through an interview, and clinical information was extracted from patient's record. Data analysis was done using SPSS software version 23 and univariate andmultivariate analyses.RESULTS Study participants consist of 256 people with T2 DM the majority of whom were women(70%), and mean age of participants was 54.06 ± 9.09. The mean of total score of PSQI was 5.56 ± 3.34. Relative to younger age group, the middle-aged people with T2 DM were twice more likely to be poor sleeper; the adjusted OR was 2.03(95%CI: 1.01-4.08); and those with longer duration of diabetes were about 1.8 times more likely to report poor quality of sleep(ORadj = 1.77, 95%CI: 0.98-3.13). Participants with cholesterol level ≥ 240 mg/dL were about twice more likely to be poor sleeper(ORadj = 1.99, 95%CI: 1.01-3.94). The odds of being poor sleeper increased as the level of distress increased(1.84-4.09).CONCLUSION As indicated by the results of the present study, some factors including age, duration of disease, psychological distress and high level of cholesterol were independently associated with poor sleep quality.
文摘目的探讨复方苦参注射液用于WHO三阶梯止痛原则中的止痛价值。方法随机选取医院2019年7月—2022年4月150例癌痛患者,按照随机数字表法分为治疗组75例,对照组75例。对照组轻度癌痛患者使用布洛芬缓释片,中度癌痛患者使用盐酸曲马多缓释片联合布洛芬缓释片,重度癌痛患者使用盐酸吗啡缓释片联合布洛芬缓释片联合醋酸地塞米松片处理,治疗组在对照组基础上加用复方苦参注射液,21 d为1个疗程。观察比较两组治疗后的疼痛有效缓解率以及疼痛程度数字评估量表(numerical rating scale,NRS)、EORTC QLQ—C30(EuroPean organization for Research and Treatment)量表评分、匹兹堡睡眠质量指数与安全性。结果经治疗,治疗组有效缓解率升高(P<0.05);治疗组的NRS评分明显升高(P<0.01);EORTC QLQ—C30量表评分部分升高(P<0.05);匹兹堡睡眠质量指数明显升高(P<0.01);两组在治疗期间均出现不良反应,但治疗组不良事件发生率在恶心呕吐与便秘两方面更低(P<0.05);结果差异均有统计学意义(P<0.05)。结论在WHO三阶梯止痛原则基础上,加用复方苦参注射液可以明显提高止痛效果,明显改善生活质量,提高患者睡眠质量,同时也可降低不良事件发生情况,因此值得在临床推广应用。
